CoChat

Gene silencing - a new theory of aging

Burzynski, Stanislaw R · 2003 · Medical Hypotheses

The DOI matches its Crossref record; 47 of the 60 references it cites were found in a registry or an index.

Abstract

The aging process involves silencing of the genes through methylation of promoter sequences and the acetylation of histones. This process contributes not only to aging, but also cancer when silencing affects tumor suppressor genes. Antineoplastons work as molecular switches, turning inactive tumor suppressor genes back on through demethylation of the DNA and acetylation of the histones. While they activate tumor suppressor genes, antineoplastons also activate some additional genes silenced during the aging process. Evidence of activation of silenced genes can be pursued by documenting the relationship between 'molecular switches' - DNA-demethylating agents and histone deacetylation inhibitors, genes which are turned on by them, and clinical anti-aging changes.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0306-9877(03)00050-1

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Research works printed but not linked: 7

  1. Kampalath, 1990, Protective effect of antineoplaston A10 in hepatocarcinogenesis induced by aflatoxin B1, Int. J. Tissue React., 12, 43
  2. Ogata, 2001, Administration of antineoplastons, biochemical anticancer agents, as a supplementary treatment after a lobectomy for liver metastases, which originated from colon cancer, Rinshou to Kenkyuu, 78, 179
  3. Burzynski SR. Antineoplaston therapy. In: Integrative Oncology Conventional and Complementary Strategies. Munich: Urban and Fischer, 2002: in press
  4. Burzynski, 1984, Human toxicology studies on oral formulation of antineoplaston A10, Drugs Exp. Clin. Res., 10, 891
  5. Burzynski, 1986, Toxicology studies of antineoplaston AS2-5 injections in cancer patients, Drugs Exp. Clin. Res., 12, 17
  6. Burzynski SR, Kubove E, Szymkowski B, Burzynski B. Phase II clinical trials of novel differentiation inducer antineoplaston AS2-1 in AIDS and asymptomatic HIV infection. In: Eighth International Conference on AIDS/III STD World Congress, Amsterdam, 1992 July
  7. Muldoon, 1990, Antineoplaston A10 activity on carcinogen-induced rat mammary tumors, Int. J. Tissue React., 12, 51

Cited by

See all 34

Metadata

Authors
Burzynski, S. R.
Affiliations
Burzynski Research Institute (US)
Corresponding author
Burzynski, Stanislaw R
Venue
Medical Hypotheses
Publisher
Elsevier BV
Published
2003-04
Volume
60
Issue
4
Pages
578-583
ISSN
0306-9877 (ISSN-L)
OpenAlex
W1998278181
Cited by
34
References
60
Citations by year
2023: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
1.15
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Medical Hypotheses (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Keywords
gene silencing, aging, DNA methylation, histone acetylation, hypomethylating agents, antineoplastons, tumor suppressor, cancer, anti-aging
MeSH terms
Aging, DNA, Histones, Humans, Models, Theoretical, DNA Methylation, Gene Silencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene silencing - a new theory of aging. https://app.cochat.ai/papers/10.1016/s0306-9877(03)00050-1
The paper
Burzynski, S. R. (2003). Gene silencing - a new theory of aging. Medical Hypotheses. https://doi.org/10.1016/s0306-9877(03)00050-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.